stockrowHumana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024.
- Revenue
- +26.1%
- EPS
- −16.7%
- Free cash flow
- +158.7%
- Total debt
- −0.82%
Quarter to September 2026, against a year earlier
Follow HUM
Alert me
Humana Inc. (HUM) Return on assets
Humana Inc.'s return on assets over the twelve months to 30 September 2026 was 2.33%, down 0.2 percentage points from fiscal 2025 (2.49%). Over the past ten years it has ranged from 2.45% (fiscal 2016) to 10.5% (fiscal 2020); the current reading is higher than 18% of that period. That is below the Healthcare Plans industry median of 3.11% and above the Healthcare sector median of −29.5%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 2.49% | (0.09) |
| FY2024 | 2.58% | (2.94) |
| FY2023 | 5.52% | (0.90) |
| FY2022 | 6.42% | (0.97) |
| FY2021 | 7.39% | (3.12) |
| FY2020 | 10.5% | 0.57 |
| FY2019 | 9.94% | 3.54 |
| FY2018 | 6.40% | (2.91) |
| FY2017 | 9.31% | 6.86 |
| FY2016 | 2.45% | (2.84) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| PGNY Progyny, Inc. compare | 12.4% |
| OSCR Oscar Health, Inc. compare | 10.9% |
| UNH UnitedHealth Group Incorporated compare | 5.06% |
| CVS CVS Health Corporation compare | 4.30% |
| ELV Elevance Health, Inc. compare | 4.10% |
| CI Cigna Group compare | 3.80% |
| HUM Humana Inc. | 2.33% |
| CNC Centene Corporation compare | 1.81% |
| MOH Molina Healthcare, Inc compare | −0.31% |
| Healthcare Plans industry median | 3.11% |
| Healthcare sector median | −29.5% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on HUM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement